WNBA Star Sentenced to 9 Years for Marijuana Possession in Russia

Dec.09.2022
WNBA Star Sentenced to 9 Years for Marijuana Possession in Russia
WNBA star Brittney Griner sentenced to nine years in Russian prison for possession of marijuana in her luggage.

According to Russian authorities, WNBA star Brittney Griner was found with a marijuana electronic pod in her carry-on luggage at a Moscow airport in February of this year. As a result, she has been sentenced to nine years in a Russian prison.


The two-time Olympic basketball champion and member of the US national team was arrested after being found in possession of a container of cannabis derivative oil.


Before announcing the verdict, Griner told the court that she inadvertently brought an electronic cigarette pod containing cannabis oil with her when she flew to Moscow to play basketball in Yekaterinburg in February.


The legality of possessing marijuana products varies by state and jurisdiction, which may impact the experiences of individuals traveling with such products.


In the United States, marijuana remains illegal under federal law.


Although cannabis is legal for adults in some states in the United States, it is still illegal according to federal law. It is not recommended to transport it across borders.


THC is the primary psychoactive substance in marijuana, while CBD is a non-psychoactive component of cannabis that is typically sold in other products such as lotions and supplements.


Certain cannabis-infused products, including CBD oil, are considered illegal at the federal level if they contain more than 0.3% delta-9-tetrahydrocannabinol (THC) by dry weight.


It is currently unclear whether the ammunition canister carried by Griner, as mentioned by Russian officials, contains either one or both of CBD or THC.


In January 2021, the organization reported that the US Food and Drug Administration has only approved one cannabis-derived product, Epidiolex, which contains purified CBD, as well as three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). These can only be obtained with a prescription from a licensed healthcare provider.


TSA Does Not Search for Drugs


Officials from the Transport Safety Management Bureau are required to report suspected illegal activities to local, state, or federal authorities, but they will not conduct searches for illegal drugs during screenings.


According to the website, TSA security personnel do not search for marijuana or other illegal drugs, but if any illegal substance is found during the security screening process, the TSA will report it to law enforcement officials.


The TSA has stated that their dogs cannot detect marijuana. However, in an Instagram post, they reiterated that in the screening process, if a substance or product infused with marijuana is found, even for medical use, law enforcement will be notified.


Carrying marijuana products while traveling abroad.


There are no specific guidelines for traveling internationally with cannabis products, but if a certain product is illegal in a particular country or region, carrying it while traveling could have consequences.


For instance, while marijuana is legal for adults in Canada, the government's tourism website states that transporting these products across the Canadian border, regardless of the amount of medical authorization, is illegal.


According to the website, this applies even if the person is traveling to and from a place where marijuana is decriminalized. The consequences of traveling with cannabis products may include being denied entry into a particular country or region.


According to the Canadian government website, "if you have used cannabis or any substance prohibited by local law in the past, you may be denied entry to your destination country." "You may also be refused entry to other countries in the future.


In recent years, Russia has arrested two women for similar reasons.


In Russia, cannabis for recreational or medicinal purposes is illegal.


In April 2019, an Israeli-American woman was arrested at Moscow airport while traveling from India to Israel and found with 9 grams of cannabis in her luggage, according to BBC News.


A 26-year-old woman, Naama Issachar, was sentenced to more than 7 years in prison for drug trafficking. According to the British Broadcasting Corporation, Russian President Vladimir Putin pardoned her in January 2020 before the visit of then-Israeli Prime Minister Benjamin Netanyahu to Moscow.


According to a report by The Moscow Times in September 2019, a film student from New York was charged with possession of drugs in St. Petersburg for allegedly bringing medical marijuana into the country.


2FIRSTS will continue to track and report on this topic, with updates available on the "2FIRSTS APP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
KIWI has launched the Spark 2 and Spark 2 Pro refillable pod systems in Germany at official prices of €18 and €29, respectively. Spark 2 uses an 800mAh removable lithium-ion battery in a pen-style body, while Spark 2 Pro features a 1,400mAh removable battery, a box-shaped design and vibration feedback every 20 puffs. Both devices use the same 2ml Spark V2 pods in 0.8Ω and 1.2Ω versions, with AirSync airflow adjustment and a choice between Cotton Tips and conventional Drip Tips. The new pods also remain compatible with the original KIWI Spark.
News
Sep.29 by 2Firsts Perspectives
Product | JTI Philippines Expands Nordic Spirit Nicotine Pouch Portfolio With Dark Pop and Red Frost
Product | JTI Philippines Expands Nordic Spirit Nicotine Pouch Portfolio With Dark Pop and Red Frost
JTI Philippines has expanded the Nordic Spirit nicotine pouch portfolio in the Philippines with two new variants, Dark Pop and Red Frost. Both products maintain the brand’s tobacco-free nicotine pouch positioning, with Dark Pop featuring a fizzy cola profile with citrus and sweet notes, while Red Frost combines cool mint with sweet red berry flavors. The two variants are now available through Philippine online retail channels.
Aug.18
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07